|
FY2025
12 months to Dec 28, 2025
|
FY2024
12 months to Dec 29, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Jan 1, 2023
|
FY2021
12 months to Jan 2, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net earnings | |||||
| Adjustments to reconcile net earnings to cash flows from operating activities: | |||||
| Depreciation and amortization of property and intangibles | |||||
| Stock based compensation | |||||
| Asset write-downs | |||||
| Charges for acquired in-process research and development | |||||
| (Gain) on separation of Kenvue | |||||
| Net gain on sale of assets/businesses | |||||
| Deferred tax provision | |||||
| Credit losses and accounts receivable allowances | |||||
| Changes in assets and liabilities, net of effects from acquisitions and divestitures: | |||||
| Increase in accounts receivable | |||||
| Increase in inventories | |||||
| Increase in accounts payable and accrued liabilities | |||||
| (Increase)/Decrease in other current and non-current assets | |||||
| (Decrease)/Increase in other current and non-current liabilities | |||||
| Net cash flows from operating activities | |||||
| Cash flows (used by) from investing activities | |||||
| Additions to property, plant and equipment | |||||
| Proceeds from the disposal of assets/businesses, net | |||||
| Acquisitions, net of cash acquired | |||||
| Acquired in-process research and development/related milestones (Note 18) | |||||
| Purchases of investments | |||||
| Sales of investments | |||||
| Credit support agreements activity, net | |||||
| Other (including capitalized licenses and milestones) | |||||
| Net cash (used by)/from investing activities | |||||
| Cash flows (used by) from financing activities | |||||
| Dividends to shareholders | |||||
| Repurchase of common stock | |||||
| Proceeds from short-term debt | |||||
| Repayment of short-term debt | |||||
| Proceeds from long-term debt, net of issuance costs | |||||
| Repayment of long-term debt | |||||
| Proceeds from the exercise of stock options/employee withholding tax on stock awards, net | |||||
| Credit support agreements activity, net | |||||
| Settlement of convertible debt acquired from Shockwave | |||||
| Proceeds of short and long-term debt, net of issuance cost, related to the debt that transferred to Kenvue at separation | |||||
| Proceeds from Kenvue initial public offering | |||||
| Cash transferred to Kenvue at separation | |||||
| Other | |||||
| Net cash used by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| (Decrease)/Increase in cash and cash equivalents | |||||
| Cash and cash equivalents from continuing operations, beginning of period | |||||
| Cash and cash equivalents from discontinued operations, beginning of period | |||||
| Cash and cash equivalents, beginning of year | |||||
| Cash and cash equivalents from continuing operations, end of period | |||||
| Cash and cash equivalents from discontinued operations, end of period | |||||
| Cash and cash equivalents, end of year | |||||
| Supplemental cash flow data | |||||
| Cash paid during the year for: | |||||
| Interest | |||||
| Interest, net of amount capitalized | |||||
| Income taxes, inclusive of discontinued operations | |||||
| Supplemental schedule of non-cash investing and financing activities | |||||
| Treasury stock issued for employee compensation and stock option plans, net of cash proceeds/ employee withholding tax on stock awards | |||||
| Fair value of assets acquired | |||||
| Fair value of liabilities assumed | |||||
| Net cash paid for acquisitions (Note 18) | |||||
Loading...